Glenmark Life Sciences IPO SUBSCRIPTION Status: FULLY subscribed! What INVESTORS should know about price band, lot size, minimum shares and other details

Glenmark Life Sciences Limited IPO was fully subscribed on Day 1 on Tuesday, as per NSE consolidated bid details. Glenmark Life Sciences Limited IPO has opened for public subscription today, July 27, 2021 and will closed on Thursday July 29.  

See Zee Business Live TV Streaming Below:

On the first day of the subscription, Glenmark Life Sciences Limited IPO saw maximum participation from Retail Individual Investors (RIIs), who already subscribed the issue twice. At 11: 50 am, the retail portion attracted bids for 1,55,72,940 shares as against its allotted quota of 75,43,130 shares.  

Besides, Retail Individual Investors, the IPO saw minimal subscription so far. Only Non Institutional Investors other than RIIs showed interest in the IPO with 0.15 times subscription, while

Qualified Institutional Buyers (QIBs) and Individuals(Other than RIIs) were yet to subscribe the issue.  

Glenmark Life Sciences Limited IPO ALL DETAILS  
Glenmark Life Sciences Limited IPO last date : July 29, 2021  
Glenmark Life Sciences Limited IPO allotment finalisation: August 3, 2021  
Glenmark Life Sciences Limited IPO refund Initiation: August 4, 2021  
Glenmark Life Sciences Limited IPO listing date: August 6, 2021  
Glenmark Life Sciences Limited IPO Issue size:  A fresh issue of equity shares worth Rs 1,060 crore and an offer for sale by existing shareholders worth Rs 453 crore 
Glenmark Life Sciences Limited IPO Price Band: Rs 695 to Rs 720 per equity share.  
Glenmark Life Sciences Limited IPO lot size: 20 equity shares and in multiples of 20 equity shares thereafter.   
Glenmark Life Sciences Limited IPO Price purchase limit on UPI: Rs 2 lakh per transaction   
Glenmark Life Sciences Limited IPO Price Band size Issue type: Book Building Process.   
Glenmark Life Sciences Limited IPO offer allocation:  15 per cent for Non-Institutional Bidders and 35 per cent Retail Individual Investor